ACM
HELP

ADAR1 Capital Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

ADAR1 Capital Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$537K Buy
81,278
+50,000
+160% +$250K 0.02% 204
2026
Q1 		$150K Sell
31,278
-207,112
-87% -$1.34M 0.01% 273
2025
Q4 		$1.95M Buy
238,390
+205,112
+616% +$1.32M 0.14% 101
2025
Q3 		$196K Buy
+33,278
New +$236K 0.02% 182

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

ADAR1 Capital Management's HELP Position: Q2 2026 in Review

ADAR1 Capital Management increased its Helus Pharma Inc. Common Stock (HELP) stake by 160% in Q2 2026, buying an estimated $250K and bringing the position to 81,278 shares worth $537K. The position accounts for 0.02% of the portfolio, ranked #204.

ADAR1 Capital Management first reported a position in HELP in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.95M in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • ADAR1 Capital Management held 81,278 shares of Helus Pharma Inc. Common Stock worth $537K as of Q2 2026.
  • ADAR1 Capital Management bought 50,000 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $250K.
  • Helus Pharma Inc. Common Stock made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #204 holding.
  • ADAR1 Capital Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2025 and has held it in 4 quarters since.
  • ADAR1 Capital Management's Helus Pharma Inc. Common Stock position peaked at $1.95M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.